City of Rochester v. Purdue Pharma L.P. et al
Consolidated
Lead case: 1:17-md-02804
Lead case: 1:17-md-02804
| Ohio Northern District Court | |
| Judge: | Dan Aaron Polster |
| Case #: | 1:19-op-45853 |
| Nature of Suit | 367 Torts - Personal Injury - Health Care/Pharmaceutical Personal Injury/Product Liability |
| Cause | No cause code entered |
| Case Filed: | Oct 17, 2019 |
| Case in other court: | New York Western, 6:19-cv-06490 |
| Last checked: Friday Nov 08, 2019 8:28 PM EST |
|
Defendant
Par Pharmaceutical Inc.
|
|
|
Defendant
Rhodes Technologies Inc.
|
|
|
Defendant
Rhodes Pharmaceuticals L.P.
|
|
|
Defendant
Rhodes Pharmaceuticals Inc.
|
|
|
Defendant
Raymond Sackler Family
|
|
|
Defendant
RHODES TECHNOLOGIES
|
|
|
Defendant
Purdue Pharma L.P.
|
|
|
Defendant
Purdue Pharma Inc
|
|
|
Defendant
Purdue Frederick Company, Inc.
|
|
|
Defendant
Publix Supermarkets, Inc.
|
|
|
Defendant
Prime Therapeutics, LLC
|
Represented By
|
|
Defendant
Richard S. Sackler
|
|
|
Defendant
Par Pharmaceutical Companies Inc.
|
|
|
Defendant
PSS World Medical, Inc.
|
|
|
Defendant
Ortho-McNeil-Janssen Pharmaceuticals, Inc. n/k/a Janssen Pharmaceuticals, Inc.
|
|
|
Defendant
OptumRX, Inc.
|
Represented By
|
|
Defendant
Optum, Inc.
|
Represented By
|
|
Defendant
Noramco Inc
|
|
|
Defendant
Navitus Holdings, LLC
|
Represented By
|
|
Defendant
Navitus Health Solutions, LLC
|
Represented By
|
|
Defendant
Mylan Pharmaceuticals Inc.
|
Represented By
|
|
Defendant
Mortimer D.A. Sackler
|
|
|
Defendant
The P.F. Laboratories, Inc.
|
|
|
Defendant
West-Ward Pharmaceuticals Corp.
|
|
|
Defendant
Watson Laboratories Inc.
|
|
|
Defendant
Walgreen Eastern Co.
|
|
|
Defendant
Walgreen Co
|
|
|
Defendant
Wal-Mart Inc.
|
Represented By
|
|
Defendant
WALGREENS BOOTS ALLIANCE INC.
|
|
|
Defendant
Value Drug Company
|
Represented By
|
|
Defendant
UnitedHealth Group Incorporated
|
Represented By
|
|
Defendant
Trust for the Benefit of Members of the Raymond Sackler Family
|
|
|
Defendant
Theresa Sackler
|
|
|
Defendant
Morris & Dickson Co LLC
|
|
|
Defendant
The Kroger Co.
|
|
|
Defendant
Teva Pharmaceuticals USA, Inc.
|
|
|
Defendant
Stuart D. Baker
|
|
|
Defendant
SpecGX LLC
|
|
|
Defendant
Smith Drug Company
|
|
|
Defendant
Sandoz Inc.
|
|
|
Defendant
SAJ Distributors
|
|
|
Defendant
Rochester Drug Co-Operative, Inc.
|
|
|
Defendant
Rite Aid of Maryland, Inc.
|
|
|
Defendant
Rite Aid Corp.
|
|
|
Defendant
Blenheim Pharmacal Inc.
|
|
|
Defendant
Discount Drug Mart, Inc.
|
|
|
Defendant
David A. Sackler
|
|
|
Defendant
Darby Group Companies, Inc.
|
|
|
Defendant
Cephalon Inc.
|
|
|
Defendant
CaremarkPCS, L.L.C.
|
Represented By
|
|
Defendant
CaremarkPCS Health, L.L.C.
|
Represented By
|
|
Defendant
Caremark Rx, L.L.C.
|
Represented By
|
|
Defendant
Caremark LLC
|
Represented By
|
|
Defendant
Cardinal Health, Inc.
|
Represented By
|
|
Defendant
CVS Health Corporation
|
Represented By
|
|
Defendant
Endo Health Solutions Inc.
|
|
|
Defendant
Beverly Sackler
|
|
|
Defendant
Bellco Drug Corp.
|
Represented By
|
|
Defendant
Anda Inc
|
|
|
Defendant
Amneal Pharmaceuticals Inc.
|
|
|
Defendant
AmerisourceBergen Drug Corporation
|
Represented By
|
|
Defendant
American Medical Distributors, Inc.
|
Represented By
|
|
Defendant
Allergan PLC f/k/a Actavis PLC
|
|
|
Defendant
Actavis, Inc. f/k/a Watson Pharmaceuticals, Inc.
|
|
|
Defendant
Actavis Pharma, Inc f/k/a Watson Pharma, Inc.
|
|
|
Defendant
Actavis LLC
|
|
|
Defendant
JOHN KAPOOR
|
Represented By
|
|
Defendant
Miami Luken, Inc.
|
|
|
Defendant
McKesson Corporation
|
|
|
Defendant
Mallinckrodt PLC
|
|
|
Defendant
Mallinckrodt LLC
|
|
|
Defendant
MORTIMER SACKLER FAMILY
|
|
|
Defendant
Kinray, LLC
|
|
|
Defendant
Kathe A. Sackler
|
|
|
Defendant
Jonathan D. Sackler
|
|
|
Defendant
Johnson & Johnson
|
|
|
Defendant
Janssen Pharmaceuticals Inc.
|
|
|
Defendant
Janssen Pharmaceutica Inc. n/k/a Janssen Pharmaceuticals, Inc.
|
|
|
Defendant
Insys Therapeutics Inc.
|
|
|
Defendant
Ilene Sackler Lefcourt
|
|
|
Defendant
Henry Schein Medical Systems, Inc.
|
|
|
Defendant
Henry Schein Inc.
|
|
|
Defendant
HBC Service Company
|
|
|
Defendant
Express Scripts Inc.
|
Represented By
|
|
Defendant
Express Scripts Holding Company
|
Represented By
|
|
Defendant
Eveready Wholesale Drugs Ltd
|
|
|
Defendant
Endo Pharmaceuticals Inc.
|
|
|
Plaintiff
The City of Rochester
|
Represented By
|
| Docket last updated: 03/02/2020 10:53 AM EST |
| Friday, June 28, 2019 | ||
| 1 | 1
NOTICE OF REMOVAL by Express Scripts, Inc., Express Scripts Holding Company from Supreme Court of the State of New York County of Monroe, case number E2019005178. (Filing fee $ 400 receipt number 0209-3504393), filed by Express Scripts, Inc., Express Scripts Holding Company.(Cogan, Jonathan) [Transferred from nywd on 10/17/2019.]
|
|
|
Att: 1
Exhibit,
|
||
|
Att: 2
Exhibit,
|
||
|
Att: 3
Civil Cover Sheet,
|
||
|
Att: 4
2 pgs
Exhibit,
|
||
|
Att: 5
322 pgs
Exhibit
|
||
| 2 | 2
NOTICE by Express Scripts Holding Company, Express Scripts, Inc. re1 Notice of Removal, (Cogan, Jonathan) [Transferred from nywd on 10/17/2019.]
|
|
| Saturday, June 29, 2019 | ||
| 3 | 3
Corporate Disclosure Statement by Express Scripts Holding Company identifying Corporate Parent Cigna Corporation for Express Scripts Holding Company.. (Cogan, Jonathan) [Transferred from nywd on 10/17/2019.]
|
|
| 4 | 4
Corporate Disclosure Statement by Express Scripts, Inc. identifying Corporate Parent Express Scripts Holding Company, Other Affiliate Cigna Corporation for Express Scripts, Inc... (Cogan, Jonathan) [Transferred from nywd on 10/17/2019.]
|
|
| Monday, July 01, 2019 | ||
| Case assigned to Hon. Frank P. Geraci, Jr.. Notification to Chambers of on-line civil opening. (TF) [Transferred from nywd on 10/17/2019.] | ||
| Notice of Availability of Magistrate Judge: A United States Magistrate of this Court is available to conduct all proceedings in this civil action in accordance with 28 U.S.C. 636c and FRCP 73. The Notice, Consent, and Reference of a Civil Action to a Magistrate Judge form (AO-85) is available for download at http://www.uscourts.gov/services-forms/forms. (TF) [Transferred from nywd on 10/17/2019.] | ||
| AUTOMATIC REFERRAL to Mediation The ADR Plan is available for download at[LINK:http://www.nywd.uscourts.gov/alternative-dispute-resolution] (TF) [Transferred from nywd on 10/17/2019.] | ||
| Notice of Potential Tag-Along Action notification emailed to the MDL (TF) [Transferred from nywd on 10/17/2019.] | ||
| Wednesday, July 10, 2019 | ||
| 5 | 5
NOTICE of Appearance by Tate James Kunkle on behalf of All Plaintiffs (Kunkle, Tate) [Transferred from nywd on 10/17/2019.]
|
|
| Thursday, July 11, 2019 | ||
| 6 | 6
NOTICE of Appearance by Alexandria E. Swette on behalf of Express Scripts Holding Company, Express Scripts, Inc. (Swette, Alexandria) [Transferred from nywd on 10/17/2019.]
|
|
| Wednesday, July 17, 2019 | ||
| 7 | 7
NOTICE of Appearance by Steven Lawrence Penaro on behalf of Optum, Inc., OptumRX, Inc., UnitedHealth Group Incorporated (Penaro, Steven) [Transferred from nywd on 10/17/2019.]
|
|
| 8 | 8
REPLY LETTER re6 Notice of Appearance filed by Express Scripts Holding Company, Express Scripts, Inc.. (TF) [Transferred from nywd on 10/17/2019.]
|
|
| Thursday, July 18, 2019 | ||
| 9 | 9
MOTION to Remand to State Court by The City of Rochester.(Kunkle, Tate) [Transferred from nywd on 10/17/2019.]
|
|
|
Att: 1
Memorandum in Support,
|
||
|
Att: 2
Declaration,
|
||
|
Att: 3
Exhibit A,
|
||
|
Att: 4
Exhibit B
|
||
| 10 | 10
MOTION to Expedite Motion to Remand by The City of Rochester.(Kunkle, Tate) [Transferred from nywd on 10/17/2019.]
|
|
|
Att: 1
Memorandum in Support,
|
||
|
Att: 2
Text of Proposed Order
|
||
| Friday, July 19, 2019 | ||
| 11 | 11 TEXT ORDER GRANTING Plaintiff's10 Motion to Expedite. Defendants' response to Plaintiff's9 Motion to Remand is due by 7/29/19, and Plaintiff may reply by 8/5/19. SO ORDERED. Signed by Hon. Frank P. Geraci, Jr. on 7/19/19. (JO) [Transferred from nywd on 10/17/2019.] | |
| Friday, July 26, 2019 | ||
| 12 | 12
MOTION for Extension of Time to File Answer re1 Notice of Removal, and the Complaint therein by American Medical Distributors, Inc., Amerisourcebergen Drug Corporation, Bellco Drug Corp..(Asfendis, Paul) [Transferred from nywd on 10/17/2019.]
|
|
|
Att: 1
Text of Proposed Order Proposed Order Extending Time to Answer, Move or Otherwise Respond to Complaint and to Conduct Fed. R. Civ. P. 26(f) Conference
|
||
| 13 | 13
MOTION to Stay All Proceedings by Express Scripts Holding Company, Express Scripts, Inc..(Swette, Alexandria) [Transferred from nywd on 10/17/2019.]
|
|
| 14 | 14
19
pgs
MEMORANDUM IN SUPPORT re13 MOTION to Stay All Proceedings byExpress Scripts Holding Company, Express Scripts, Inc..(Swette, Alexandria) [Transferred from nywd on 10/17/2019.]
|
|
|
Att: 1
Declaration,
|
||
|
Att: 2
Exhibit,
|
||
|
Att: 3
Exhibit,
|
||
|
Att: 4
Exhibit,
|
||
|
Att: 5
Exhibit,
|
||
|
Att: 6
Exhibit,
|
||
|
Att: 7
Exhibit,
|
||
|
Att: 8
Exhibit,
|
||
|
Att: 9
Exhibit,
|
||
|
Att: 10
Exhibit,
|
||
|
Att: 11
Exhibit,
|
||
|
Att: 12
Text of Proposed Order
|
||
| Monday, July 29, 2019 | ||
| ATTENTION CORPORATION PLAINTIFFS/DEFENDANTS: All Corporate Disclosure Statements pursuant to Fed.R.Civ.7.1(b) are to be filed within seven(7) days of this notice. (CGJ) [Transferred from nywd on 10/17/2019.] | ||
| 15 | 15 TEXT ORDER: On 7/26/19, Defendants Cardinal Health Inc., AmerisourceBergen Drug Corporation, Bellco Drug Corp., McKesson Corporation, and PSS World Medical, Inc., (the Distributor Defendants) filed a12 motion for extension of time to respond to Plaintiff's Complaint. The Motion is hereby GRANTED, and the time for the Distributor Defendants to answer, move, or otherwise respond to the Complaint and to conduct the Ruled 26(f) planning conference is extended until sixty (60) days following: (1) this Courts ruling on any motion to remand, or (2) a final decision by the Judicial Panel on Multidistrict Litgation on transfer of this action to the Opiate Multidistrict Litigation, whichever is later. SO ORDERED. Signed by Hon. Frank P. Geraci, Jr. on 7/29/19. (JO) [Transferred from nywd on 10/17/2019.] | |
| 16 | 16 TEXT ORDER: On 7/26/19, Defendants Express Scripts Holding Company, Express Scripts, Inc., CVS Health Corporation, Caremark Rx, L.L.C., CaremarkPCS Health, L.L.C. d/b/a CVS/Caremark, Caremark, L.L.C., CaremarkPCS, L.L.C., UnitedHealth Group Incorporated, Optum, Inc., OptumRx, Inc., Prime Therapeutics, LLC, Navitus Holdings, LLC, and Navitus Health Solutions, LLC, (the Moving Defendants) moved to stay all proceedings in this case pending the Judicial Panel on Multidistrict Litigation's ruling on whether to transfer this case to the Opiate Multidistrict Litigation in the Northern District of Ohio. Plaintiff's response is due by 8/5/19, and the Moving Defendants may reply by 8/12/19. SO ORDERED. Signed by Hon. Frank P. Geraci, Jr. on 7/29/19. (JO) [Transferred from nywd on 10/17/2019.] | |
| 17 | 17
NOTICE of Appearance by Charles E. Graney on behalf of Value Drug Company (Graney, Charles) [Transferred from nywd on 10/17/2019.]
|
|
| 18 | 18
13
pgs
MEMORANDUM in Opposition re9 MOTION to Remand to State Court (with attached Certificate of Service) filed by Value Drug Company. (Graney, Charles) [Transferred from nywd on 10/17/2019.]
|
|
| 19 | 19
MOTION for Joinder for a Temporary Stay of Proceedings Pending Final Ruling by the Judicial Panel on Multidistrict Litigation & Memorandum in Support regarding Dkt Nos.[13 & 14] by Value Drug Company.(Graney, Charles) [Transferred from nywd on 10/17/2019.]
|
|
| 20 | 20
30+
pgs
MEMORANDUM in Opposition re9 MOTION to Remand to State Court filed by Express Scripts Holding Company, Express Scripts, Inc..(Swette, Alexandria) [Transferred from nywd on 10/17/2019.]
|
|
|
Att: 1
Declaration,
|
||
|
Att: 2
Exhibit,
|
||
|
Att: 3
Exhibit,
|
||
|
Att: 4
Exhibit,
|
||
|
Att: 5
Exhibit,
|
||
|
Att: 6
Exhibit,
|
||
|
Att: 7
Exhibit,
|
||
|
Att: 8
Exhibit
|
||
| Tuesday, July 30, 2019 | ||
| 21 | 21
Consent MOTION for Extension of Time to File Answer re1 Notice of Removal, and the Complaint therein on behalf of CVS Health Corporation, Caremark Rx, L.L.C., Caremark, L.L.C., CaremarkPCS Health, L.L.X., CaremarkPCS, L.L.C., Walgreen Co.; Walgreen Eastern Co.; Walgreens Boots Alliance, Inc.; Rite Aid Corporation and Rite Aid of Maryland, Inc. d/b/a Rite Aid Mid Atlantic Customer Support Center; Walmart Inc., Prime Therapeutics LLC, Navitus Holdings, LLC, Navitus Health Solutions, LLC, UnitedHealth Group Incorporated, Optum, Inc., OptumRx, Inc., Express Scripts Holding Company, Express Scripts, Inc., and Anda, Inc. by CVS Health Corporation, Caremark Rx, L.L.C., Caremark, L.L.C., CaremarkPCS Health, L.L.C. D/B/A CVS / Caremark, CaremarkPCS, L.L.C..(Naunton, Shawn) [Transferred from nywd on 10/17/2019.]
|
|
|
Att: 1
Exhibit A (Proposed Order Extending Time to Answer, Move of Otherwise Respond to Complaint and To Conduct Fed. R. Civ. P. 26(f) Conference)
|
||
| 22 | 22
Corporate Disclosure Statement by Optum, Inc. identifying Corporate Parent UnitedHealth Group Incorporated, Other Affiliate UnitedHealthCare Services, Inc. for Optum, Inc... (Penaro, Steven) [Transferred from nywd on 10/17/2019.]
|
|
| 23 | 23
Corporate Disclosure Statement by OptumRX, Inc. identifying Corporate Parent UnitedHealth Group Incorporated, Other Affiliate OptumRx Holdings, LLC for OptumRX, Inc... (Penaro, Steven) [Transferred from nywd on 10/17/2019.]
|
|
| 24 | 24
Corporate Disclosure Statement by UnitedHealth Group Incorporated. (Penaro, Steven) [Transferred from nywd on 10/17/2019.]
|
|
| Wednesday, July 31, 2019 | ||
| 25 | 25 TEXT ORDER: On 7/30/19, Defendants CVS Health Corporation, Caremark Rx, L.L.C., Caremark, L.L.C., CaremarkPCS Health, L.L.C., CaremarkPCS, L.L.C., Walgreen Co., Walgreen Eastern Co., Walgreens Boots Alliance, Inc., Rite Aid Corporation and Rite Aid of Maryland, Inc. d/b/a Rite Aid Mid Atlantic Customer Support Center, Walmart Inc., Prime Therapeutics LLC, Navitus Holdings, LLC, Navitus Health Solutions, LLC, UnitedHealth Group Incorporated, Optum, Inc., OptumRx, Inc., Express Scripts Holding Company, Express Scripts, Inc., and Anda, Inc., filed an unopposed21 motion for an extension of time to respond to Plaintiff's Complaint. The Motion is hereby GRANTED, and the Moving Defendants may answer, move, or otherwise respond to the Complaint and conduct the Rule 26(f) planning conference sixty (60) days following: (1) this Court's ruling on any motion to remand, or (2) a final decision by the Judicial Panel on Multidistrict Litgation on transfer of this action to the Opiate Multidistrict Litigation, whichever is later. The Court acknowledges that the Moving Defendants only requested a thirty-day extension. The Court uses its discretion to extend the time to sixty days to keep the response deadline uniform for all Defendants. SO ORDERED. Signed by Hon. Frank P. Geraci, Jr. on 7/31/19. (JO) [Transferred from nywd on 10/17/2019.] | |
| Monday, August 05, 2019 | ||
| 26 | 26
Corporate Disclosure Statement by American Medical Distributors, Inc., Amerisourcebergen Drug Corporation, Bellco Drug Corp. identifying Corporate Parent AmerisourceBergen Corporation, Corporate Parent AmerisourceBergen Services Corporation for Amerisourcebergen Drug Corporation, Bellco Drug Corp... (Asfendis, Paul) [Transferred from nywd on 10/17/2019.]
|
|
| 27 | 27
NOTICE of Appearance by Franklin C. McRoberts on behalf of Cardinal Health Inc. (McRoberts, Franklin) [Transferred from nywd on 10/17/2019.]
|
|
| 28 | 28
Corporate Disclosure Statement by Cardinal Health Inc.. (McRoberts, Franklin) [Transferred from nywd on 10/17/2019.]
|
|
| 29 | 29
Corporate Disclosure Statement by Value Drug Company. (Graney, Charles) [Transferred from nywd on 10/17/2019.]
|
|
| 30 | 30
NOTICE of Appearance by Phoebe A. Wilkinson on behalf of Mylan Pharmaceuticals, Inc. (Wilkinson, Phoebe) [Transferred from nywd on 10/17/2019.]
|
|
| 31 | 31
Corporate Disclosure Statement by Mylan Pharmaceuticals, Inc. identifying Corporate Parent Mylan Inc., Corporate Parent Mylan N.V. for Mylan Pharmaceuticals, Inc... (Wilkinson, Phoebe) [Transferred from nywd on 10/17/2019.]
|
|
| 32 | 32
NOTICE of Appearance by Nicholas Shea Davis on behalf of Navitus Health Solutions, LLC, Navitus Holdings, LLC (Davis, Nicholas) [Transferred from nywd on 10/17/2019.]
|
|
| 33 | 33
Corporate Disclosure Statement by Navitus Health Solutions, LLC, Navitus Holdings, LLC identifying Corporate Parent Dean Health Systems, Inc., Corporate Parent FPP, Inc., Corporate Parent SSM Health Care Corporation for Navitus Health Solutions, LLC, Navitus Holdings, LLC.. (Davis, Nicholas) [Transferred from nywd on 10/17/2019.]
|
|
| 34 | 34
NOTICE of Appearance by James W. Carlson on behalf of Wal-Mart Inc. (Carlson, James) [Transferred from nywd on 10/17/2019.]
|
|
| 35 | 35
Corporate Disclosure Statement by Wal-Mart Inc.. (Carlson, James) [Transferred from nywd on 10/17/2019.]
|
|
| 36 | 36
REPLY to Response to Motion re9 MOTION to Remand to State Court filed by The City of Rochester.(Kunkle, Tate) [Transferred from nywd on 10/17/2019.]
|
|
|
Att: 1
Exhibit 1- MDL Order Regarding Remands
|
||
| 37 | 37
RESPONSE in Opposition re13 MOTION to Stay All Proceedings filed by The City of Rochester.(Kunkle, Tate) [Transferred from nywd on 10/17/2019.]
|
|
|
Att: 1
Exhibit 1- MDL Order Regarding Remands
|
||
| Tuesday, August 06, 2019 | ||
| 38 | 38
NOTICE of Appearance by Steven G. Kobre on behalf of Express Scripts Holding Company, Express Scripts, Inc. (Kobre, Steven) [Transferred from nywd on 10/17/2019.]
|
|
| 39 | 39
NOTICE of Appearance by Matthew I. Menchel on behalf of Express Scripts Holding Company, Express Scripts, Inc. (Menchel, Matthew) [Transferred from nywd on 10/17/2019.]
|
|
| 40 | 40
NOTICE of Appearance by Paul Edward Asfendis on behalf of Amerisourcebergen Drug Corporation, Bellco Drug Corp. (Asfendis, Paul) [Transferred from nywd on 10/17/2019.]
|
|
| 41 | 41
MOTION to appear pro hac vice by Adriana Riviere-Badell ( Filing fee $ 150 receipt number 0209-3543738.) by Express Scripts Holding Company, Express Scripts, Inc..(Swette, Alexandria) [Transferred from nywd on 10/17/2019.]
|
|
|
Att: 1
Exhibit Admission application
|
||
| 42 | 42
MOTION to appear pro hac vice by Julian Park ( Filing fee $ 150 receipt number 0209-3543794.) by Express Scripts Holding Company, Express Scripts, Inc..(Swette, Alexandria) [Transferred from nywd on 10/17/2019.]
|
|
|
Att: 1
Exhibit Admission application
|
||
| Wednesday, August 07, 2019 | ||
| 43 | 43
NOTICE of Appearance by Jillian Kay Farrar on behalf of Prime Therapeutics LLC (Farrar, Jillian) [Transferred from nywd on 10/17/2019.]
|
|
| Thursday, August 08, 2019 | ||
| 44 | 44
DECISION AND ORDER GRANTING Defendants Express Scripts Holding Company and Express Scripts, Inc.,'s motions to admit Adriana Riviere-Badell and Julian W. Park pro hac vice . SO ORDERED. Signed by Hon. Frank P. Geraci, Jr. on 8/8/19. (JO) -CLERK TO FOLLOW UP- [Transferred from nywd on 10/17/2019.]
|
|
| 45 | 45
Corporate Disclosure Statement by Prime Therapeutics LLC.(Farrar, Jillian) [Transferred from nywd on 10/17/2019.]
|
|
|
Att: 1
Certificate of Service
|
||
| Monday, August 12, 2019 | ||
| 46 | 46
REPLY to Response to Motion re13 MOTION to Stay All Proceedings filed by Express Scripts, Inc..(Swette, Alexandria) [Transferred from nywd on 10/17/2019.]
|
|
|
Att: 1
Declaration of Alexandria E. Swette,
|
||
|
Att: 2
Exhibit 1
|
||
| Tuesday, August 20, 2019 | ||
| 47 | 47
NOTICE of Appearance by Kacey Houston Walker on behalf of John K. Kapoor (Walker, Kacey) [Transferred from nywd on 10/17/2019.]
|
|
| 48 | 48
Letter filed by Value Drug Company as to Jonathan D. Sackler, Richard S. Sackler, Saj Distributors, Amerisourcebergen Drug Corporation, Walgreen, Co., Johnson & Johnson, CaremarkPCS Health, L.L.C. D/B/A CVS / Caremark, Kinray, LLC, Insys Therapeutics, Inc., Wal-Mart Inc., Actavis LLC, Trust for the Benefit of Members of the Raymond Sackler Family, Amneal Pharmaceuticals, Inc., Optum, Inc., The Kroger Co., PSS World Medical, Inc., John K. Kapoor, Morris & Dickson Co., LLC, Cardinal Health Inc., Ortho-McNeil-Janssen Pharmaceuticals, Inc. n/k/a Janssen Pharmaceuticals, Inc., Mortimer Sackler Family, Kathe A. Sackler, Endo Health Solutions Inc., Express Scripts, Inc., Par Pharmaceutical Companies, Inc., Navitus Holdings, LLC, Express Scripts Holding Company, Smith Drug Company, Darby Group Companies, Inc., Mallinckrodt LLC, David A. Sackler, Value Drug Company, Anda, Inc., Rhodes Technologies Inc., Endo Pharmaceuticals, Inc., Watson Laboratories, Inc., Caremark, L.L.C., Mylan Pharmaceuticals, Inc., HBC Service Company, Noramco, Inc., Miami-Luken, Inc., CVS Health Corporation, The P.F. Laboratories, Inc., Prime Therapeutics LLC, Henry Schein Medical Systems, Inc., McKesson Corporation, Publix Supermarkets, Inc., West-Ward Pharmaceuticals Corp. N/K/A Hikma Pharmaceuticals, Inc., Rite Aid of Maryland, Inc., D/B/A Rite Aid Mid-Atlantic Customer Support Center, Inc., Walgreen Eastern Co., Rite Aid Corp., Actavis Pharma, Inc. f/k/a Watson Pharma, Inc., Purdue Pharma L.P., Navitus Health Solutions, LLC, Raymond Sackler Family, CaremarkPCS, L.L.C., Eveready Wholesale Drugs Ltd., Rochester Drug Cooperative, Inc., UnitedHealth Group Incorporated, Henry Schein, Inc., Rhodes Technologies, Actavis, Inc. F/K/A Watson Pharmaceuticals, Inc., Discount Drug Mart, Inc., Walgreens Boots Alliance, Inc., Mallinckrodt PLC, Blenheim Pharmacal, Inc., Sandoz, Inc., Caremark Rx, L.L.C., American Medical Distributors, Inc., Rhodes Pharmaceuticals L.P., Stuart D. Baker, Bellco Drug Corp., Allergan PLC F/K/A Actavis PLC, Cephalon, Inc., OptumRX, Inc., Purdue Pharma Inc., Ilene Sackler Lefcourt, Janssen Pharmaceutica Inc. n/k/a Janssen Pharmaceuticals, Inc., SpecGx LLC, Par Pharmaceutical, Inc., Janssen Pharmaceuticals, Inc., Theresa Sackler, Purdue Frederick Company, Inc., Mortimer D.A. Sackler, Beverly Sackler, Rhodes Pharmaceuticals Inc., Teva Pharmaceuticals USA, Inc. VALUE DRUG COMPANY'S ("VLD") LETTER TO JUDGE GERACI DATED 8/20/19 requesting that the Court grant this application on consent and enter an order extending the time for VDC to answer, move, or otherwise respond to the Complaint and to conduct the Rule 26(f) planning conference until 60 days following: (1) a final decision by the JPML on transfer of this action to the Opiate MDL; or (2) this Courts ruling on Plaintiffs motion to remand, whichever is later). .(Graney, Charles) [Transferred from nywd on 10/17/2019.]
|
|
|
Att: 1
Exhibit [PROPOSED ORDE]
|
||
| Wednesday, August 21, 2019 | ||
| 49 | 49 TEXT ORDER: Defendant Value Drug Company's Unopposed Letter Request for an Extension of Time48 is GRANTED. Defendant Value Drug Company may answer, move, or otherwise respond to the Complaint and conduct the Rule 26(f) planning conference sixty (60) days following: (1) this Court's ruling on any motion to remand, or (2) a final decision by the Judicial Panel on Multidistrict Litigation on transfer of this action to the Opiate Multidistrict Litigation, whichever is later. SO ORDERED. Signed by Hon. Frank P. Geraci, Jr. on 8/21/2019. (MFM) [Transferred from nywd on 10/17/2019.] | |
| Thursday, August 22, 2019 | ||
| 50 | 50
STIPULATION regarding Service of the Summons and Complaint by CVS Health Corporation, Caremark Rx, L.L.C., Caremark, L.L.C., CaremarkPCS Health, L.L.C. D/B/A CVS / Caremark, CaremarkPCS, L.L.C.. (Naunton, Shawn) [Transferred from nywd on 10/17/2019.]
|
|
| Thursday, August 29, 2019 | ||
| 51 | 51
Corporate Disclosure Statement by Caremark, L.L.C. identifying Corporate Parent CVS Health Corporation for Caremark, L.L.C... (Naunton, Shawn) [Transferred from nywd on 10/17/2019.]
|
|
| 52 | 52
Corporate Disclosure Statement by Caremark Rx, L.L.C. identifying Corporate Parent CVS Health Corporation for Caremark Rx, L.L.C... (Naunton, Shawn) [Transferred from nywd on 10/17/2019.]
|
|
| 53 | 53
Corporate Disclosure Statement by CaremarkPCS, L.L.C. identifying Corporate Parent CVS Health Corporation for CaremarkPCS, L.L.C... (Naunton, Shawn) [Transferred from nywd on 10/17/2019.]
|
|
| 54 | 54
Corporate Disclosure Statement by CaremarkPCS Health, L.L.C. D/B/A CVS / Caremark identifying Corporate Parent CVS Health Corporation for CaremarkPCS Health, L.L.C. D/B/A CVS / Caremark.. (Naunton, Shawn) [Transferred from nywd on 10/17/2019.]
|
|
| 55 | 55
Corporate Disclosure Statement by CVS Health Corporation. (Naunton, Shawn) [Transferred from nywd on 10/17/2019.]
|
|
| Friday, August 30, 2019 | ||
| 56 | 56
MOTION for Extension of Time to File Answer by John K. Kapoor.(Walker, Kacey) [Transferred from nywd on 10/17/2019.]
|
|
|
Att: 1
Exhibit A
|
||
| Tuesday, September 03, 2019 | ||
| 57 | 57 TEXT ORDER: Defendant John K. Kapoor's unopposed56 Motion for an Extension of Time is GRANTED. Defendant may answer, move, or otherwise respond to the Complaint sixty (60) days following: (1) this Court's ruling on any motion to remand, or (2) a final decision by the Judicial Panel on Multidistrict Litigation on transfer of this action to the Opiate Multidistrict Litigation, whichever is later. SO ORDERED. Signed by Hon. Frank P. Geraci, Jr. on 9/3/19. (JO) [Transferred from nywd on 10/17/2019.] | |
| Wednesday, September 04, 2019 | ||
| 58 | 58
Letter filed by Mylan Pharmaceuticals, Inc. as to Jonathan D. Sackler, Richard S. Sackler, Saj Distributors, Amerisourcebergen Drug Corporation, Walgreen, Co., Johnson & Johnson, CaremarkPCS Health, L.L.C. D/B/A CVS / Caremark, Kinray, LLC, Insys Therapeutics, Inc., Wal-Mart Inc., Actavis LLC, Trust for the Benefit of Members of the Raymond Sackler Family, Amneal Pharmaceuticals, Inc., Optum, Inc., The Kroger Co., PSS World Medical, Inc., John K. Kapoor, Morris & Dickson Co., LLC, Cardinal Health Inc., Ortho-McNeil-Janssen Pharmaceuticals, Inc. n/k/a Janssen Pharmaceuticals, Inc., Mortimer Sackler Family, Kathe A. Sackler, Endo Health Solutions Inc., Express Scripts, Inc., Par Pharmaceutical Companies, Inc., Navitus Holdings, LLC, Express Scripts Holding Company, Smith Drug Company, Darby Group Companies, Inc., Mallinckrodt LLC, David A. Sackler, Value Drug Company, Anda, Inc., Rhodes Technologies Inc., Endo Pharmaceuticals, Inc., Watson Laboratories, Inc., Caremark, L.L.C., Mylan Pharmaceuticals, Inc., HBC Service Company, Noramco, Inc., Miami-Luken, Inc., CVS Health Corporation, The P.F. Laboratories, Inc., Prime Therapeutics LLC, Henry Schein Medical Systems, Inc., McKesson Corporation, Publix Supermarkets, Inc., West-Ward Pharmaceuticals Corp. N/K/A Hikma Pharmaceuticals, Inc., Rite Aid of Maryland, Inc., D/B/A Rite Aid Mid-Atlantic Customer Support Center, Inc., Walgreen Eastern Co., Rite Aid Corp., Actavis Pharma, Inc. f/k/a Watson Pharma, Inc., Purdue Pharma L.P., Navitus Health Solutions, LLC, Raymond Sackler Family, CaremarkPCS, L.L.C., Eveready Wholesale Drugs Ltd., Rochester Drug Cooperative, Inc., UnitedHealth Group Incorporated, Henry Schein, Inc., Rhodes Technologies, Actavis, Inc. F/K/A Watson Pharmaceuticals, Inc., Discount Drug Mart, Inc., Walgreens Boots Alliance, Inc., Mallinckrodt PLC, Blenheim Pharmacal, Inc., Sandoz, Inc., Caremark Rx, L.L.C., American Medical Distributors, Inc., Rhodes Pharmaceuticals L.P., Stuart D. Baker, Bellco Drug Corp., Allergan PLC F/K/A Actavis PLC, Cephalon, Inc., OptumRX, Inc., Purdue Pharma Inc., Ilene Sackler Lefcourt, Janssen Pharmaceutica Inc. n/k/a Janssen Pharmaceuticals, Inc., SpecGx LLC, Par Pharmaceutical, Inc., Janssen Pharmaceuticals, Inc., Theresa Sackler, Purdue Frederick Company, Inc., Mortimer D.A. Sackler, Beverly Sackler, Rhodes Pharmaceuticals Inc., Teva Pharmaceuticals USA, Inc. requesting that the time for Mylan to answer, move, or otherwise respond to the Complaint, and to conduct the FRCP 26(f) planning conference be extended until sixty (60) days following: (1) this Courts ruling on any motion to remand, or (2) a final decision by the Judicial Panel on Multidistrict Litigation on transfer of this action to the multidistrict litigation for opioid-related actions, whichever is later . (Wilkinson, Phoebe) [Transferred from nywd on 10/17/2019.]
|
|
| Thursday, September 05, 2019 | ||
| E-Filing Notification:58 Letter filed by Mylan Pharmaceuticals, Inc.. This document contains a request for relief and should be filed as a motion. ACTION REQUIRED: Re-file document using the motion event. (TF) [Transferred from nywd on 10/17/2019.] | ||
| 59 | 59
MOTION for Extension of Time to File Answer by Mylan Pharmaceuticals, Inc..(Wilkinson, Phoebe) [Transferred from nywd on 10/17/2019.]
|
|
|
Att: 1
Exhibit A - Proposed Order
|
||
| 60 | 60 TEXT ORDER: Defendant Mylan Pharmaceuticals, Inc.'s unopposed58 letter request for an Extension of Time is GRANTED. Defendant may answer, move, or otherwise respond to the Complaint sixty (60) days following: (1) this Court's ruling on any motion to remand, or (2) a final decision by the Judicial Panel on Multidistrict Litigation on transfer of this action to the Opiate Multidistrict Litigation, whichever is later. SO ORDERED. Signed by Hon. Frank P. Geraci, Jr. on 9/5/19. (JO) [Transferred from nywd on 10/17/2019.] | |
| Friday, September 13, 2019 | ||
| 61 | 61
NOTICE by Express Scripts, Inc. re13 MOTION to Stay All Proceedings of Supplemental Authority (Swette, Alexandria) [Transferred from nywd on 10/17/2019.]
|
|
| Monday, September 23, 2019 | ||
| 62 | 62 TEXT ORER: On 6/28/19, Defendants removed this case from state court. ECF No.1 . In response, Plaintiff moved to remand the case back to state court. ECF No.9 . Defendants replied by moving to temporarily stay the case pending a final decision from the Judicial Panel on Multidistrict Litigation (JPML) regarding whether the case will be transferred to the Opiate Multidistrict Litigation in the Northern District of Ohio. ECF Nos.13 ,19 . After reviewing the parties' materials in support of and opposition to the motion to stay, the Court GRANTS Defendants' motion to stay. The Court finds that doing so promotes judicial economy and consistency and reduces the net hardship experienced by both parties. See In re Ivy , 901 F.2d 7, 9 (1990). If the case is not transferred, the Court will then consider Plaintiff's motion to remand. The parties are ordered to submit a joint status report within fourteen (14) days of the JPML's hearing currently scheduled for 9/26/19. SO ORDERED. Signed by Hon. Frank P. Geraci, Jr. on 9/23/19. (JO) [Transferred from nywd on 10/17/2019.] | |
| Wednesday, October 02, 2019 | ||
| 63 | 63
MULTIDISTRICT LITIGATION TRANSFER ORDER to the Northern District of Ohio and, with the consent of that court, assigned to the Honorable Dan A. Polster. Signed by Sarah S. Vance, Chair Panel on Multidistrict Litigation on 10/2/19. (TF) [Transferred from nywd on 10/17/2019.]
|
|
| 64 | 64
CERTIFIED MULTIDISTRICT LITIGATION TRANSFER ORDER to the Northern District of Ohio and, with the consent of that court, assigned to the Honorable Dan A. Polster. Signed by Sarah S. Vance, Chair Panel on Multidistrict Litigation on 10/2/19(TF) [Transferred from nywd on 10/17/2019.]
|
|
| Thursday, October 17, 2019 | ||
| 65 | 65
CASE TRANSFERRED IN from District of New York Western. Case number 6:19-cv-06490. Original file, certified copy of transfer order and docket sheet received.
|
|